WFM
ARRY

Wilmington Funds Management’s Array Biopharma Inc ARRY Stock Holding History

Wilmington Funds Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$159K Sell
34,890
-6,290
-15% -$26K 0.02% 692
2014
Q1 		$194K Sell
41,180
-10,623
-21% -$53.4K 0.02% 697
2013
Q4 		$260K Sell
51,803
-2,470
-5% -$13.4K 0.03% 601
2013
Q3 		$338K Sell
54,273
-960
-2% -$5.7K 0.03% 520
2013
Q2 		$251K Buy
+55,233
New +$297K 0.02% 586

Other funds holding ARRY

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Wilmington Funds Management's ARRY Position: Q2 2014 in Review

Wilmington Funds Management reduced its Array Biopharma Inc (ARRY) stake by 15% in Q2 2014, selling an estimated $26K and leaving 34,890 shares worth $159K. The position accounts for 0.02% of the portfolio, ranked #692.

Wilmington Funds Management first reported a position in ARRY in Q2 2013 and has held it in 5 quarters since. The position peaked at $338K in Q3 2013. 129 funds tracked by Wall St. Rank hold ARRY as of Q2 2014.

  • Wilmington Funds Management held 34,890 shares of Array Biopharma Inc worth $159K as of Q2 2014.
  • Wilmington Funds Management sold 6,290 Array Biopharma Inc shares in Q2 2014, an estimated $26K.
  • Array Biopharma Inc made up 0.02% of Wilmington Funds Management's portfolio in Q2 2014, its #692 holding.
  • Wilmington Funds Management first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Funds Management's Array Biopharma Inc position peaked at $338K in Q3 2013.
  • 129 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.